宫腔镜联合左炔诺孕酮宫内缓释系统治疗子宫内膜息肉临床效果

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:jizhe621
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨宫腔镜联合左炔诺孕酮宫内释放系统治疗子宫内膜息肉临床效果。方法 108例子宫内膜息肉患者随机分为观察组和对照组,各54例。对照组采用宫腔镜治疗,观察组在宫腔镜治疗后放置左炔诺孕酮宫内释放系统,对两组患者随访6个月,比较两组患者的治疗效果、月经量、经期、血红蛋白、子宫内膜厚度。结果观察组治疗总有效率为98.15%,明显高于对照组的83.33%,两组比较差异有统计学意义(P<0.05);治疗6个月后观察组患者月经量少于对照组,经期短于对照组,子宫内膜厚度比对照组薄,血红蛋白量明显高于对照组,两组各值比较差异均有统计学意义(P<0.05)。结论宫腔镜联合左炔诺孕酮宫内释放系统治疗子宫内膜息肉可缩短经期,减少月经量、子宫内膜厚度,提高血红蛋白量,具有显著临床治疗效果,值得在临床中推广应用。 Objective To investigate the clinical effect of hysteroscopy combined with levonorgestrel releasing intrauterine system in the treatment of endometrial polyps. Methods 108 patients with endometrial polyps were randomly divided into observation group and control group, each 54 cases. The control group was treated with hysteroscopy. The observation group was given levonardgestrel intrauterine release system after hysteroscopic treatment. The two groups were followed up for 6 months. The therapeutic effect, menstrual flow, menstrual period, hemoglobin , Endometrial thickness. Results The total effective rate of the observation group was 98.15%, significantly higher than that of the control group (83.33%), the difference was statistically significant (P <0.05). After 6 months of treatment, the observation group had less menstrual flow than the control group, Shorter than the control group, the thickness of the endometrium was thinner than the control group, and the hemoglobin level was significantly higher than that of the control group. There was significant difference between the two groups (P <0.05). Conclusion hysteroscopy combined with levonorgestrel release of intrauterine system for the treatment of endometrial polyps can shorten the menstrual period, reduce menstrual flow, endometrial thickness, increase the amount of hemoglobin, has a significant clinical effect, it is worth to promote the clinical application.
其他文献
目的探讨乌司他丁对行急诊经皮冠状动脉介入治疗(percutaneous coronary interventions, PCI)患者炎症介质的干预作用及对心功能的影响。方法68例行急诊PCI的患者,随机分为治
目的探讨布地奈德联合复方异丙托溴胺氧驱动雾化吸入治疗毛细支气管炎的临床疗效。方法将72例临床明确诊断为毛细支气管炎的患儿随机分为治疗组34例与对照组38例,两组在常规
目的观察注射型唑来膦酸盐治疗骨质疏松的临床疗效,优化临床治疗效果。方法 114例骨质疏松患者,按随机数字表分为观察组和对照组,各57例。对照组给予钙剂与活性维生素D治疗,
目的比较布地奈德福莫特罗与孟鲁司特治疗支气管哮喘的疗效。方法 198例接受治疗的支气管哮喘患者,按照随机数字表法随机分为A组与B组,各99例。观察两组患者一秒用力呼气容积
目的探究疏血通注射液辅助治疗高脂血症性急性胰腺炎病症的效果。方法 90例高脂血症性急性胰腺炎(HAP)患者,随机分为观察组和对照组,每组45例。两组患者都给予常规治疗,观察
目的:探讨盐酸罗哌卡因与布比卡因在妇科肿瘤手术中的应用效果,并对其安全性进行比较分析。方法106例子宫肌瘤患者随机分成观察组和对照组,每组53例。观察组患者采用盐酸罗哌卡
目的探讨巴曲酶与银杏达莫联合治疗脑梗死的疗效观察。方法 90例脑梗死患者,随机分为治疗组和对照组,各45例。对照组采用银杏达莫进行治疗,治疗组采用巴曲酶与银杏达莫联合用
目的:观察步长稳心颗粒联合骨化三醇胶丸治疗心血管神经症的临床效果。方法130例心血管神经症患者,随机分为观察组(稳心颗粒联合骨化三醇胶丸组)和对照组(西药常规治疗组),每组6
目的探讨盐酸替罗非班在冠心病治疗中的安全性。方法 77例冠心病患者,按照治疗方式的不同分为对照组和观察组,对照组38例,观察组39例。对照组患者在经皮冠状动脉介入治疗(PCI)
目的探讨应用喜炎平、重组人干扰素联合中药制剂治疗儿童手足口病(HFMD)的临床效果。方法 226例手足口病患儿,随机分为观察组和对照组。对照组110例给予常规治疗,观察组116例在